.-Myocardial aging leads to a reduction of -adrenergic receptor-induced metabolic and contractile responsiveness. We hypothesize that a change in the patterns of gene expression is important in these age-related events. To test this, hearts were harvested from young and aged male rats (3-4 and 20-22 mo, respectively). Total mRNA was extracted and prepared for hybridization to Affymetrix U34A GeneChips. Filtering criteria, involving fold change and a statistical significance cutoff were employed, yielding 263 probe pairs exhibiting differential signals. Of the 163 annotated genes, at least 56 (34%) were classified as signaling/cell communication. Of these 56, approximately half were directly involved in G protein-coupled receptor signaling pathways. We next determined which of these changes might be involved in anti-adrenergic activity and identified 19 potentially important gene products. Importantly, we observed a decrease in 1-adrenergic receptor and adenylyl cyclase mRNAs, whereas the mRNA encoding -arrestin increased. Furthermore, the results demonstrate an increase in mRNAs encoding the adenosine A1 receptor and phospholipase D, which could increase anti-adrenergic effects. Moreover, the mRNAs encoding the muscarinic M3 receptor, nicotinic acetylcholine receptor 3, and nicotinic acetylcholine receptor-related protein were increased as was the mRNA encoding guanylate kinase-associated protein. Interestingly, we also observed eight mRNAs whose abundance changed three-to sixfold with aging that could be considered as being compensatory. Although these results do not prove causality, they demonstrate that cardiac aging is associated with changes in the profiles of gene expression and that many of these changes may contribute to reduced adrenergic signaling. gene expression; aging; anti-adrenergic; G protein-coupled receptors; physiological genomics THE ABILITY OF THE HEART to respond to excitatory signaling cues is the dominant regulator of cardiac function. The hallmark of the aged heart is an impairment of the excitatory response to -adrenergic agonists leading to a deficit in cardiac contractility and metabolism (26,27). The -adrenergic signaling system also plays a central role in the pathophysiology of congestive heart failure (17). Despite the importance of this system, the factors that contribute to a decreased responsiveness in signaling, particularly with aging, are unclear.The -adrenergic signaling cascade is composed of membrane receptors, signal transducers, and downstream effector molecules. The receptor-signaling cascade is dynamically regulated by the phosphorylation state catalyzed by common and pathway-specific enzymes. Although the individual candidate approach has provided some clues as to the changes that occur with aging, the basic premise guiding these studies is that the determinants of -adrenergic responsiveness will be few and the regulatory circuits will be simple. However, it is clear that the signaling pathways for membrane receptors are not simple but are highly integrated a...